pharma · Acute Myeloid Leukemia · Breast Cancer
First People's Hospital
The First People's Hospital of Lianyungang
First People's Hospital is a pharma organization headquartered in SAN DIEGO, CA, CN. Primary therapeutic focus areas include Acute Myeloid Leukemia, Breast Cancer, Gastric Cancer, Multiple Myeloma, Esophageal Squamous Ce
SAN DIEGO, CA, CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- SAN DIEGO, CA, CN
- Programs
- 1136
- Drugs
- 626
- Patents
- 123
Sintilimab with Interleukin-2+CAPOX
Phase 2 · small molecule · Locally Advanced Rectal Adenocarcinoma
Sintilimab with Interleukin-2+CAPOX for Locally Advanced Rectal Adenocarcinoma is a Phase 2 program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).
Internal code PRSYM202310
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- The First People's Hospital of Lianyungang
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Locally Advanced Rectal Adenocarcinoma
- Status
- completed
- Trials
- 1